Aspira Women's Health(us:AWH)

    0.7700

    +0.65%

    Updated on 2024-12-22

    Open:0.7520
    Close:0.7700
    High:0.7920
    Low:0.7102
    Pre Close:0.7650
    Volume:85206.00
    Amount:62646.09
    Turnover:0.51%
    Shares:16.67M
    MarketCap:12.83M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-3028139585410.88%596
    2024-03-3126189251415.33%2107
    2023-12-31297153246.72%5108
    2023-09-30266578366.39%499
    2023-06-30476747947.96%2636
    2023-03-31535917950.47%61316
    2022-12-316197251777.81%5630
    2022-09-30781266537910.18%91136
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Armistice Capital, Llc11570009.37%1157000
    2024-03-31Vanguard Group Inc2774072.25%8140041.53%
    2024-03-31B. Riley Wealth Advisors, Inc.1253741.02%-53997-30.10%
    2024-03-31Blackrock Inc.627660.51%0
    2024-03-31Geode Capital Management, Llc595440.48%22153.86%
    2024-03-31Quantum Private Wealth, Llc524180.42%22624.51%
    2024-03-31Northern Trust Corp333350.27%-2714-7.53%
    2024-03-31Bank Of America Corp /De/293540.24%1710.59%
    2024-03-31Squarepoint Ops Llc254380.21%1007365.56%
    2024-03-31Northeast Financial Consultants Inc234360.19%0

    About

    Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
    Address:12117 Bee Caves Road,Suite 100,Building III

    Market Movers